Stromacel Inc (OTC Pink - No Information:PROT)

0.009
Delayed Data
As of Jun 29
 0.00 / 0.00%
Today’s Change
0.01
Today|||52-Week Range
0.04
-26.83%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Biotechnology
MARKET CAP
$71.2K

Company Description

Proteonomix, Inc. is a biotechnology company engaged in the discovery and development of stem cell therapeutic and cosmeceutical products. It is developing pre clinical-stage therapeutic agents and treatments for diabetes, heart, and lung diseases. The company's discoveries involve non embryonic stem cell treatments. It operates through the following segments: the sperm bank division, the stem-cell division, the skin care products division, PRTMI, Thor and StromaCel. Proteonomix was founded by Michael Moshe Cohen on June 26, 1995 and is headquartered in Hawthorne, NJ.

Contact Information

Proteonomix, Inc.
140 East Ridgewood Avenue
Paramus New Jersey 07652
P:(973) 949-4195
Investor Relations:

Employees

Shareholders

Mutual fund holders--
Individual stakeholders--
Other institutional--

Top Executives

Michael Moshe CohenChairman, President, CEO, COO, CAO & Controller
Thomas Peter MonahanChief Financial Officer
Steven Mark ByleDirector & Chief Technology Officer
Roger L. FidlerTreasurer, Director & General Counsel
Jason B. IsaacsSecretary

To view my watchlist

Not a member yet?

Sign up now for a free account